YORK,
England, June 24, 2021 /PRNewswire/ --
DeepVerge (LSE: DVRG.L), today announces the successful
completion of Phase 3 field trials in which Microtox® PD
achieved real-time detection and transmission of data, specific to
SARS-CoV-2, in wastewater treatment plants at multiple sites.
As a result, its Environmental Health Division ("Modern
Water") has entered into a master service agreement with EPS Group
to install, calibrate, service and maintain
Microtox® PD units which, subject to negotiation
with undisclosed parties, have the potential to be installed in
multiple European countries.
Gerard Brandon, DeepVerge plc
CEO commented:
"The successful completion of the Phase 3 field trials
clearly demonstrates the capability and value of
Microtox® PD to identify dangerous pathogens,
including SARS-CoV-2, in real-time. By establishing a
permanent anonymised mass surveillance of wastewater, DeepVerge
claims a world first real-time defence against this global
pandemic. The installation of Microtox® PD wastewater
units will enable live data to simultaneously identify the source
of COVID-19 cases as well as identify COVID-19 clusters with the
ability to indicate the size of each cluster. As the data
grows, the central AI system has the potential to predict the
trajectory of growth of future clusters of SARS-CoV-2 or any future
dangerous pathogen .
"Having achieved this major milestone, we are delighted to
enter this agreement with EPS Group who complete the final step of
installing, retrofitting and maintaining our Microtox®
PD equipment. With this level of established technical
engineering support and distribution, DeepVerge can now offer an
end-to-end solution for public and private clients across the
European wastewater sector. We expect updates from our Joint
Venture agreement with China Resources and roll-out in the US to
follow early in Q3. "
Patrick Buckley, EPS Group
Managing Director commented:
"We are very pleased to be part of this innovative
partnership with DeepVerge to help combat the pandemic with their
unique Microtox® PD technology playing a crucial
role in the early detection of COVID-19 hotspots around the world.
With 550 personnel, our largest footprint in the water, wastewater
pumping and treatment services sector across Europe, EPS Group engineers are ready to make
this happen".
Background to field trials:
On the 24 September 2020, the
Company announced completion of the integration of an
Affimer/Aptamer-based real-time SARS-CoV-2 detector and alert
system into Modern Water's Microtox water contamination system, now
called Microtox® PD , for the detection of the
coronavirus in wastewater. Microtox® PD
successfully completed initial spike protein testing and
validation of SARS-CoV-2 in filtered wastewater and transitioned to
the University of Aberdeen for full
beta testing of the system using real SARS-CoV-2 virus samples in
its containment level 3 laboratory, prior to initiation of the
field trials, referred to above.
Contacts
DeepVerge plc
Gerard Brandon, CEO
+44 (0) 7340 055 648
SPARK Advisory Partners Limited
(Nominated Adviser)
Neil Baldwin/Andrew Emmott
+44 (0) 113 370 8974
Turner Pope Investments (TPI) Limited (Broker)
Andy Thacker/James Pope
+44 (0) 20 3657 0050
https://www.londonstockexchange.com/news-article/DVRG/microtox-successful-phase-3-field-trials/15030475
View original
content:http://www.prnewswire.com/news-releases/deepverge-plc-microtox-pd-claims-world-first-live-data-alerts-of-sars-cov-2-in-wastewater-treatment-plants-301319205.html
SOURCE DeepVerge PLC